Literature DB >> 21484808

First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Baojian Wu1, Kaustubh Kulkarni, Sumit Basu, Shuxing Zhang, Ming Hu.   

Abstract

Glucuronidation mediated by UDP-glucuronosyltransferases (UGTs) is a significant metabolic pathway that facilitates efficient elimination of numerous endobiotics and xenobiotics, including phenolics. UGT genetic deficiency and polymorphisms or inhibition of glucuronidation by concomitant use of drugs are associated with inherited physiological disorders or drug-induced toxicities. Moreover, extensive glucuronidation can be a barrier to oral bioavailability as the first-pass glucuronidation (or premature clearance by UGTs) of orally administered agents usually results in the poor oral bioavailability and lack of efficacies. This review focused on the first-pass glucuronidation of phenolics including natural polyphenols and pharmaceuticals. The complexity of UGT-mediated metabolism of phenolics is highlighted with species-, gender-, organ- and isoform-dependent specificity, as well as functional compensation between UGT1A and 2B subfamily. In addition, recent advances are discussed with respect to the mechanisms of enzymatic actions, including the important properties such as binding pocket size and phosphorylation requirements.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484808      PMCID: PMC3409645          DOI: 10.1002/jps.22568

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  210 in total

Review 1.  Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels.

Authors:  Karl Walter Bock
Journal:  Biochem Pharmacol       Date:  2010-05-08       Impact factor: 5.858

2.  Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.

Authors:  Silvio Aprile; Erika Del Grosso; Giorgio Grosa
Journal:  Drug Metab Dispos       Date:  2010-04-07       Impact factor: 3.922

3.  Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells.

Authors:  Yan Pang; Dejan Nikolic; Dongwei Zhu; Lucas R Chadwick; Guido F Pauli; Norman R Farnsworth; Richard B van Breemen
Journal:  Mol Nutr Food Res       Date:  2007-07       Impact factor: 5.914

Review 4.  Resveratrol bioavailability and toxicity in humans.

Authors:  Charles-Henry Cottart; Valérie Nivet-Antoine; Christelle Laguillier-Morizot; Jean-Louis Beaudeux
Journal:  Mol Nutr Food Res       Date:  2010-01       Impact factor: 5.914

5.  Pharmacokinetics of 3H-phenylephrine in man.

Authors:  J H Hengstmann; J Goronzy
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Authors:  E Beutler; T Gelbart; A Demina
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

7.  The fate of naringin in humans: a key to grapefruit juice-drug interactions?

Authors:  U Fuhr; A L Kummert
Journal:  Clin Pharmacol Ther       Date:  1995-10       Impact factor: 6.875

8.  Targeted inhibition of glucuronidation markedly improves drug efficacy in mice - a model.

Authors:  Nikhil K Basu; Labanyamoy Kole; Mousumi Basu; Antony F McDonagh; Ida S Owens
Journal:  Biochem Biophys Res Commun       Date:  2007-06-14       Impact factor: 3.575

9.  The major chemical-detoxifying system of UDP-glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C.

Authors:  Nikhil K Basu; Labanyamoy Kole; Mousumi Basu; Kushal Chakraborty; Partha S Mitra; Ida S Owens
Journal:  J Biol Chem       Date:  2008-06-13       Impact factor: 5.157

10.  Mechanistic study on the intestinal absorption and disposition of baicalein.

Authors:  Li Zhang; Ge Lin; Bernadette Kovács; Márton Jani; Peter Krajcsi; Zhong Zuo
Journal:  Eur J Pharm Sci       Date:  2007-04-09       Impact factor: 4.384

View more
  66 in total

1.  Accurate prediction of glucuronidation of structurally diverse phenolics by human UGT1A9 using combined experimental and in silico approaches.

Authors:  Baojian Wu; Xiaoqiang Wang; Shuxing Zhang; Ming Hu
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

2.  Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.

Authors:  Jacqueline Ramírez; Snezana Mirkov; Larry K House; Mark J Ratain
Journal:  Drug Metab Dispos       Date:  2015-04-13       Impact factor: 3.922

3.  Recipient mucosal-associated invariant T cells control GVHD within the colon.

Authors:  Antiopi Varelias; Mark D Bunting; Kate L Ormerod; Motoko Koyama; Stuart D Olver; Jasmin Straube; Rachel D Kuns; Renee J Robb; Andrea S Henden; Leanne Cooper; Nancy Lachner; Kate H Gartlan; Olivier Lantz; Lars Kjer-Nielsen; Jeffrey Yw Mak; David P Fairlie; Andrew D Clouston; James McCluskey; Jamie Rossjohn; Steven W Lane; Philip Hugenholtz; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 4.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

Review 5.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

Review 6.  Bioavailability of phytochemicals and its enhancement by drug delivery systems.

Authors:  Farrukh Aqil; Radha Munagala; Jeyaprakash Jeyabalan; Manicka V Vadhanam
Journal:  Cancer Lett       Date:  2013-02-19       Impact factor: 8.679

Review 7.  Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes.

Authors:  Kyu-Ho Han; Naoto Hashimoto; Michihiro Fukushima
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 8.  Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.

Authors:  Dong Dong; Roland Ako; Ming Hu; Baojian Wu
Journal:  Xenobiotica       Date:  2012-03-02       Impact factor: 1.908

9.  Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.

Authors:  Baojian Wu; Shuxing Zhang; Ming Hu
Journal:  Mol Pharm       Date:  2011-10-21       Impact factor: 4.939

10.  Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD).

Authors:  Jiawang Liu; Shilong Zheng; Victoria L Akerstrom; Chester Yuan; Youning Ma; Qiu Zhong; Changde Zhang; Qiang Zhang; Shanchun Guo; Peng Ma; Elena V Skripnikova; Melyssa R Bratton; Antonio Pannuti; Lucio Miele; Thomas E Wiese; Guangdi Wang
Journal:  J Med Chem       Date:  2016-08-29       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.